Share

March 11, 2014; 82 (10) ArticleOpen Access

Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis

Anna Karin Hedström, Izaura Lima Bomfim, Lisa Barcellos, Milena Gianfrancesco, Catherine Schaefer, Ingrid Kockum, Tomas Olsson, Lars Alfredsson
First published February 5, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000203
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2770

Share

Article Information

vol. 82 no. 10 865-872
DOI: 
https://doi.org/10.1212/WNL.0000000000000203
PubMed: 
24500647
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 14, 2013
  • Accepted in final form November 1, 2013
  • First Published February 5, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Anna Karin Hedström, MD,
    2. Izaura Lima Bomfim, PhD,
    3. Lisa Barcellos, PhD,
    4. Milena Gianfrancesco, MPH,
    5. Catherine Schaefer, PhD,
    6. Ingrid Kockum, PhD,
    7. Tomas Olsson, PhD* and
    8. Lars Alfredsson, PhD*
  1. Anna Karin Hedström, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Izaura Lima Bomfim, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Lisa Barcellos, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Milena Gianfrancesco, MPH,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Catherine Schaefer, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Ingrid Kockum, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Tomas Olsson, PhD* and
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Lars Alfredsson, PhD*
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Institute of Environmental Medicine (A.K.H.), Neuroimmunology Unit, Department of Clinical Neuroscience (I.L.B., I.K.), and the Institute of Environmental Medicine (L.A.), Karolinska Institutet, Stockholm, Sweden; Genetic Epidemiology and Genomics Lab (L.B., M.G.), Division of Epidemiology, School of Public Health, University of California, Berkeley; Kaiser Permanente Division of Research (C.S.), Oakland, CA; Center for Molecular Medicine (I.K.) and Neuroimmunology Unit, Department of Clinical Neuroscience and Center for Molecular Medicine (T.O.), Karolinska Institutet at Karolinska University Hospital, Solna; and Centre for Occupational and Environmental Medicine (L.A.), Stockholm County Council, Sweden.
  1. Correspondence to Dr. Hedström: anna.hedstrom{at}ki.se
View Full Text

Article usage

Article usage: February 2014 to December 2022

AbstractFullPdfSource
Feb 20145491137Highwire
Mar 20142313108176Highwire
Apr 201444121177Highwire
May 20143444544Highwire
Jun 20142626350Highwire
Jul 20141174639Highwire
Aug 2014792121Highwire
Sep 2014772617Highwire
Oct 2014883032Highwire
Nov 2014792717Highwire
Dec 2014661213Highwire
Jan 20151002316Highwire
Jan 201503113pmc
Feb 2015442316Highwire
Feb 20150177pmc
Mar 2015852320Highwire
Mar 20150208pmc
Apr 2015602310Highwire
Apr 201503716pmc
May 2015382419Highwire
May 201502917pmc
Jun 201546912Highwire
Jun 201502213pmc
Jul 2015491212Highwire
Jul 201502016pmc
Aug 2015461616Highwire
Aug 20150155pmc
Sep 201538159Highwire
Sep 20150339pmc
Oct 2015221317Highwire
Oct 201503030pmc
Nov 2015521211Highwire
Nov 20150228pmc
Dec 201546238Highwire
Dec 20150247pmc
Jan 2016271512Highwire
Jan 20160264pmc
Feb 2016451115Highwire
Feb 201601910pmc
Mar 2016321212Highwire
Mar 201603112pmc
Apr 201623108Highwire
Apr 20160125pmc
May 2016301414Highwire
May 20160175pmc
Jun 201644621Highwire
Jun 20160396pmc
Jul 201618419Highwire
Jul 20160257pmc
Aug 201627717Highwire
Aug 20160146pmc
Sep 201632915Highwire
Sep 20160155pmc
Oct 2016401122Highwire
Oct 20160236pmc
Nov 201643525Highwire
Nov 20160164pmc
Dec 201646613Highwire
Dec 20160216pmc
Jan 201741109Highwire
Jan 20170283pmc
Feb 20173051Highwire
Feb 20170144pmc
Mar 20175155Highwire
Mar 20170156pmc
Apr 20174356Highwire
Apr 2017267pmc
May 20174097Highwire
May 201761314pmc
Jun 20172333Highwire
Jun 2017499pmc
Jul 20173284Highwire
Jul 201741416pmc
Aug 20172647Highwire
Aug 2017698pmc
Sep 20171862Highwire
Sep 201711215pmc
Oct 201730911Highwire
Oct 201761519pmc
Nov 20173366Highwire
Nov 201751416pmc
Dec 201713277Highwire
Jan 2018122713Highwire
Feb 201812136Highwire
Mar 2018261111Highwire
Apr 20181219712Highwire
Apr 201841314pmc
May 20183618915Highwire
Jun 2018261235Highwire
Jun 201871313pmc
Jul 2018229312Highwire
Aug 201827538Highwire
Aug 201872035pmc
Sep 201819276Highwire
Oct 2018296016Highwire
Nov 201822689Highwire
Dec 201821665Highwire
Jan 201929597Highwire
Feb 2019187114Highwire
Mar 20191712623Highwire
Apr 20191913518Highwire
May 2019911411Highwire
Jun 2019127410Highwire
Jul 20192218326Highwire
Aug 20191827815Highwire
Sep 20192027015Highwire
Oct 20192229622Highwire
Nov 20191820033Highwire
Dec 20193311019Highwire
Jan 2020142819Highwire
Feb 2020141924Highwire
Mar 2020162631Highwire
Apr 2020124226Highwire
May 2020182237Highwire
Jun 2020293316Highwire
Jul 202081511Highwire
Aug 20205106Highwire
Sep 2020194951Highwire
Oct 2020215533Highwire
Nov 2020204935Highwire
Dec 2020184230Highwire
Jan 2021272531Highwire
Feb 2021373732Highwire
Mar 2021173722Highwire
Apr 2021172311Highwire
May 2021274138Highwire
Jun 2021114019Highwire
Jul 2021124023Highwire
Aug 2021214015Highwire
Sep 2021233825Highwire
Oct 2021134828Highwire
Nov 2021163656Highwire
Dec 2021183723Highwire
Jan 2022214534Highwire
Feb 2022226038Highwire
Mar 2022284338Highwire
Apr 2022294244Highwire
May 2022214146Highwire
Jun 202283215Highwire
Jul 202215258Highwire
Aug 2022113021Highwire
Sep 202282922Highwire
Oct 2022293729Highwire
Nov 2022203925Highwire
Dec 202272423Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me